Outcome of elderly undergoing extracorporeal life support in refractory cardiogenic shock

Clinical Research in Cardiology

Volumn 106, Issue 5, 2017, Pages 379-385

  de Waha, Suzanne ^a,b   Graf, Tobias ^a,b   Desch, Steffen ^a,b   Fuernau, Georg ^a,b   Eitel, Ingo ^a,b   Pöss, Janine ^a,b   Jobs, Alexander ^a,b   Stiermaier, Thomas ^a,b   Ledwoch, Jakob ^a,b   Wiedau, Ariane ^c   Lurz, Philipp ^c   Schuler, Gerhard ^c   Thiele, Holger ^a,b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^c UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Active support device; Age; Extracorporeal life support; Prognosis; Refractory cardiogenic shock

Indexed keywords

FRESH FROZEN PLASMA;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; ASSESSMENT OF HUMANS; BLEEDING; CARDIOGENIC SHOCK; CARDIOVASCULAR PROCEDURE; CAUSE OF DEATH; CEREBRAL PERFORMANCE CATEGORY SCALE; EXTRACORPOREAL LIFE SUPPORT; FEMALE; FOLLOW UP; HEMODYNAMICS; HEMOLYSIS; HOSPITAL MORTALITY; HUMAN; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MULTIPLE ORGAN FAILURE; OUTCOME ASSESSMENT; PROGNOSIS; RENAL REPLACEMENT THERAPY; SEPTIC SHOCK; STRUCTURED QUESTIONNAIRE; AGE DISTRIBUTION; CHRONIC DISEASE; CLINICAL TRIAL; EPIDEMIOLOGY; EXTRACORPOREAL OXYGENATION; GERMANY; INCIDENCE; LONGITUDINAL STUDY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PREVALENCE; RISK FACTOR; SURVIVAL RATE; TREATMENT OUTCOME; UTILIZATION;

AGE DISTRIBUTION; AGED; CHRONIC DISEASE; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; GERMANY; HOSPITAL MORTALITY; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; RISK FACTORS; SHOCK, CARDIOGENIC; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 85009476477     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-016-1068-8     Document Type: Article

References (24)

1. Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, de Waha A, Richardt G, Hennersdorf M, Empen K, Fuernau G, Desch S, Eitel I, Hambrecht R, Lauer B, Bohm M, Ebelt H, Schneider S, Werdan K, Schuler G (2013) Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Lancet 382(9905):1638–1645. doi:10.1016/S0140-6736(13)61783-3
2. Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, Buller CE, Jacobs AK, Slater JN, Col J, McKinlay SM, LeJemtel TH (1999) Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med 341(9):625–634. doi:10.1056/NEJM199908263410901
3. Thiele H, Zeymer U, Werdan K (2013) Intraaortic balloon support for cardiogenic shock. N Engl J Med 368(1):81. doi:10.1056/NEJMc1213513
4. Investigators T, Alexander JH, Reynolds HR, Stebbins AL, Dzavik V, Harrington RA, Van de Werf F, Hochman JS (2007) Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial. JAMA 297(15):1657–1666. doi:10.1001/jama.297.15.joc70035
5. Paden ML, Conrad SA, Rycus PT, Thiagarajan RR (2012) Extracorporeal life support organization registry report 2012. ASAIO J 59(3):202–210. doi:10.1097/MAT.0b013e3182904a52
6. Sauer CM, Yuh DD, Bonde P (2015) Extracorporeal membrane oxygenation use has increased by 433% in adults in the United States from 2006 to 2011. ASAIO J 61(1):31–36. doi:10.1097/MAT.0000000000000160
7. Beurtheret S, Mordant P, Paoletti X, Marijon E, Celermajer DS, Leger P, Pavie A, Combes A, Leprince P (2013) Emergency circulatory support in refractory cardiogenic shock patients in remote institutions: a pilot study (the cardiac-RESCUE program). Eur Heart J 34(2):112–120. doi:10.1093/eurheartj/ehs081
8. Sheu JJ, Tsai TH, Lee FY, Fang HY, Sun CK, Leu S, Yang CH, Chen SM, Hang CL, Hsieh YK, Chen CJ, Wu CJ, Yip HK (2010) Early extracorporeal membrane oxygenator-assisted primary percutaneous coronary intervention improved 30-day clinical outcomes in patients with ST-segment elevation myocardial infarction complicated with profound cardiogenic shock. Crit Care Med 38(9):1810–1817. doi:10.1097/CCM.0b013e3181e8acf7
9. Schmidt M, Burrell A, Roberts L, Bailey M, Sheldrake J, Rycus PT, Hodgson C, Scheinkestel C, Cooper DJ, Thiagarajan RR, Brodie D, Pellegrino V, Pilcher D (2015) Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score. Eur Heart J 36 (33):2246–2256. doi:10.1093/eurheartj/ehv194
10. Combes A, Leprince P, Luyt CE, Bonnet N, Trouillet JL, Leger P, Pavie A, Chastre J (2008) Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock. Crit Care Med 36(5):1404–1411. doi:10.1097/CCM.0b013e31816f7cf7
11. Aubin H, Petrov G, Dalyanoglu H, Saeed D, Akhyari P, Paprotny G, Richter M, Westenfeld R, Schelzig H, Kelm M, Kindgen-Milles D, Lichtenberg A, Albert A (2016) A suprainstitutional network for remote extracorporeal life support: a retrospective cohort study. JACC Heart Fail 4(9):698–708. doi:10.1016/j.jchf.2016.03.018
12. Dzavik V, Sleeper LA, Cocke TP, Moscucci M, Saucedo J, Hosat S, Jiang X, Slater J, LeJemtel T, Hochman JS, Investigators S (2003) Early revascularization is associated with improved survival in elderly patients with acute myocardial infarction complicated by cardiogenic shock: a report from the SHOCK Trial Registry. Eur Heart J 24(9):828–837
13. de Waha S, Fuernau G, Desch S, Eitel I, Wiedau A, Lurz P, Schuler G, Thiele H (2016) Long-term prognosis after extracorporeal life support in refractory cardiogenic shock: results from a real-world cohort. EuroIntervention 11(12):1363–1371. doi:10.4244/EIJV11I12A265
14. Le Gall JR, Lemeshow S, Saulnier F (1993) A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA 270(24):2957–2963
15. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33(14):1787–1847. doi:10.1093/eurheartj/ehs104
16. Tendera M, Aboyans V, Bartelink ML, Baumgartner I, Clement D, Collet JP, Cremonesi A, De Carlo M, Erbel R, Fowkes FG, Heras M, Kownator S, Minar E, Ostergren J, Poldermans D, Riambau V, Roffi M, Rother J, Sievert H, van Sambeek M, Zeller T (2011) ESC guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the task force on the diagnosis and treatment of peripheral artery diseases of the European Society of Cardiology (ESC). Eur Heart J 32(22):2851–2906. doi:10.1093/eurheartj/ehr211
17. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD) (2009). Kidney Int Suppl (113):S1–S130. doi:10.1038/ki.2009.188
18. Werdan K, Russ M, Buerke M, Delle-Karth G, Geppert A, Schondube FA (2012) Cardiogenic shock due to myocardial infarction: diagnosis, monitoring and treatment: a German–Austrian S3 guideline. Dtsch Arztebl Int 109(19):343–351. doi:10.3238/arztebl.2012.0343
19. Cummins RO, Chamberlain D, Hazinski MF, Nadkarni V, Kloeck W, Kramer E, Becker L, Robertson C, Koster R, Zaritsky A, Bossaert L, Ornato JP, Callanan V, Allen M, Steen P, Connolly B, Sanders A, Idris A, Cobbe S (1997) Recommended guidelines for reviewing, reporting, and conducting research on in-hospital resuscitation: the in-hospital ‘Utstein style’. American Heart Association. Circulation 95(8):2213–2239
20. Abrams D, Combes A, Brodie D (2014) Extracorporeal membrane oxygenation in cardiopulmonary disease in adults. J Am Coll Cardiol 63 (25 Pt A):2769–2778. doi:10.1016/j.jacc.2014.03.046
21. Ouweneel DM, Henriques JP (2012) Percutaneous cardiac support devices for cardiogenic shock: current indications and recommendations. Heart 98(16):1246–1254. doi:10.1136/heartjnl-2012-301963
22. Werdan K, Gielen S, Ebelt H, Hochman JS (2013) Mechanical circulatory support in cardiogenic shock. Eur Heart J 35(3):156–167. doi:10.1093/eurheartj/eht248
23. Hochman JS, Skolnick AH (2009) Contemporary management of cardiogenic shock: age is opportunity. JACC Cardiovasc Interv 2(2):153–155. doi:10.1016/j.jcin.2008.12.002
24. Bo M, Massaia M, Raspo S, Bosco F, Cena P, Molaschi M, Fabris F (2003) Predictive factors of in-hospital mortality in older patients admitted to a medical intensive care unit. J Am Geriatr Soc 51(4):529–533